Patent application number | Description | Published |
20090192293 | ANTIBODIES TO NON-FUNCTIONAL P2X7 RECEPTOR - The present invention provides antibodies that specifically bind to P2X | 07-30-2009 |
20100036101 | ANTIBODIES AGAINST NON FUNCTIONAL P2X7 RECEPTOR - A recombinant or synthetic antibody or fragment thereof, said antibody or fragment thereof including three complementarity determining regions (CDR1 | 02-11-2010 |
20110092674 | Non-Functional P2X7 Receptor - The present invention provides antibodies that specifically bind to P2X | 04-21-2011 |
20110110959 | ANTI-P2X7 PEPTIDES AND EPITOPES - The invention relates to the identification of a novel epitope on non-functional P2X | 05-12-2011 |
20120059151 | Non-Functional P2X7 Receptor - The present invention provides antibodies that specifically bind to P2X | 03-08-2012 |
20120329076 | Antibodies to Non-Functional Oligomeric P2X7 Receptors - The invention relates to purinergic receptors, to antibodies and related fragments thereof for binding to said receptors, to production of said antibodies and fragments and to use of said antibodies and fragments for cancer detection and therapy. In particular the antibodies described bind specifically to non-functional P2X7 receptors expressed by live cells. | 12-27-2012 |
20130171666 | Purinergic (P2X) Receptors in Extra-Cellular Body Fluid - The invention relates to purinergic (P2X) receptors, to detection of protein in extra-cellular body fluids and to anti-bodies for the diagnosis or condition, especially cancer. | 07-04-2013 |
20130245226 | Antibodies To Non-Functional P2X7 Receptor - The present invention provides antibodies that specifically bind to P2X | 09-19-2013 |
20130266592 | COMPANION ANIMAL TREATMENTS - The invention relates to minimising the progression of cancer in a companion animal using P2X7 immunotherapy. | 10-10-2013 |
20130273085 | Novel P2X7 Epitopes - The invention relates to purinergic (P2X) receptors, more specifically to P2X7 receptors, the generation of antibodies and the use of antibodies and immunogens that are capable of selectively binding to a non ATP-binding P2X7 receptor but not to an ATP-binding P2X7 receptor, for the detection and treatment of disease conditions, especially cancer. | 10-17-2013 |
20140135475 | ANTIBODIES FOR BINDING TO NON-FUNCTIONAL P2X7 RECEPTORS IN TRIMERIC FORM - The invention relates to a novel epitope on P2X7 receptors, to antibodies for binding to the epitope and to peptides for generating the antibodies. | 05-15-2014 |
20140323693 | Antibodies To Non-Functional P2X7 Receptor - The present invention provides antibodies that specifically bind to P2X7 receptors and distinguish between functional and non-functional p2X7 receptors, pharmaceutical compositions and kits containing the antibodies, and methods of using the antibodies for the detection, diagnosis and treatment of disease conditions. | 10-30-2014 |